Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01881009 · ClinicalTrials.gov registry record · NA
Medtronic Minimed Overnight Closed-Loop System
A NA study of Diabetes Mellitus, Type 1 and Type 1 Diabetes Mellitus, sponsored by Bruce A. Buckingham.
- Completed
- Registry status
- NA
- Development phase
- 37
- Enrollment target
- 1
- Study location
NCT01881009 is a NA study of Diabetes Mellitus, Type 1 and Type 1 Diabetes Mellitus that has completed, run by Bruce A. Buckingham. The registered enrollment target is 37 participants, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01881009, a NA study of Diabetes Mellitus, Type 1 and Type 1 Diabetes Mellitus, has completed, sponsored by Bruce A. Buckingham.
- COMPLETED
- Registry status
- NA
- Development phase
- 37 participants
- Enrollment target
- 1
- Study location
Study Summary
To test the function and safety of the Medtronic Overnight Closed Loop (OCL) System in a closely monitored 12 hour overnight inpatient study. Once the safety of the device has been validated we will move the study to an outpatient diabetes camp setting. The camp setting will allow us to obtain pilot efficacy and safety data in a "real-life" environment. We plan to compare the subject control nights to the subject nights on the OCL system to assess the percent of sensor glucose readings in the target range of 70-150 mg/dl. Based on previous research, we anticipate that the use of the OCL system will contribute to a greater percentage of sensor glucose readings in the target range.
Conditions Studied
Interventions
- DEVICE Hybrid Closed-loop System
- DEVICE Sensor-augmented pump
Study Locations (1)
California
- Stanford University - Stanford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 37 participants |
| Start Date | 2013-06 |
| Est. Completion | 2013-08-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01881009
The ClinicalTrials.gov registry entry for NCT01881009 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,266-participant average among 118 other Diabetes Mellitus, Type 1 trials with a reported enrollment target (97% lower). The listed sponsor is Bruce A. Buckingham, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 4 conditions, with Diabetes Mellitus, Type 1 appearing as the primary indexed condition, and to 2 interventions - of which Hybrid Closed-loop System is the first listed.
NCT01881009 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01881009 about?
NCT01881009 is a clinical study titled "Medtronic Minimed Overnight Closed-Loop System". To test the function and safety of the Medtronic Overnight Closed Loop (OCL) System in a closely monitored 12 hour overnight inpatient study. Once the safety of the device has been validated we will move the study to an outpatient diabetes camp setting. The camp setting will allow us to obtain pilot...
What is the current status of trial NCT01881009?
This trial is currently completed. It is a NA study. The enrollment target is 37 participants. The study started on 2013-06. Estimated completion is 2013-08-03.
What conditions does trial NCT01881009 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Type 1, Type 1 Diabetes Mellitus, Autoimmune Diabetes, Juvenile-Onset Diabetes.
What interventions are being tested in trial NCT01881009?
The interventions under investigation include: Hybrid Closed-loop System (DEVICE), Sensor-augmented pump (DEVICE).
Who is sponsoring clinical trial NCT01881009?
This trial is sponsored by Bruce A. Buckingham, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01881009 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus, Type 1
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes
RECRUITING · NA
-
Best Practice Advisories to Reduce Inequities in Technology Use for People With Type 1 Diabetes
RECRUITING · NA
-
Diabetes Learning in Virtual Environments Just in Time for Community Reentry
RECRUITING · NA
-
Efficacy and Safety of a Ketogenic Diet in Type 1 Diabetes
RECRUITING · NA
-
National Institute of Diabetes and Digestive Kidney Diseases* Share Plus: Continuous Glucose Monitoring with Data Sharing in Older Adults with Type 1 Diabetes* and Their Care Partners to Improve Time in Range and Reduce Diabetes Distress.
RECRUITING · NA
-
Randomized Trial of Supplemental Synchronous and Asynchronous Telehealth to Improve Glycemic Control for Pediatric Patients With Type 1 Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.